Prognostic evaluation of categorical platelet-based indices using clustering methods based on the Monte Carlo comparison for hepatocellular carcinoma

Asian Pac J Cancer Prev. 2014;15(14):5721-7. doi: 10.7314/apjcp.2014.15.14.5721.

Abstract

Objectives: To evaluate the performance of clustering methods used in the prognostic assessment of categorical clinical data for hepatocellular carcinoma (HCC) patients in China, and establish a predictable prognostic nomogram for clinical decisions.

Materials and methods: A total of 332 newly diagnosed HCC patients treated with hepatic resection during 2006-2009 were enrolled. Patients were regularly followed up at outpatient clinics. Clustering methods including the Average linkage, k-modes, fuzzy k-modes, PAM, CLARA, protocluster, and ROCK were compared by Monte Carlo simulation, and the optimal method was applied to investigate the clustering pattern of the indices including platelet count, platelet/lymphocyte ratio (PLR) and serum aspartate aminotransferase activity/platelet count ratio index (APRI). Then the clustering variable, age group, tumor size, number of tumor and vascular invasion were studied in a multivariable Cox regression model. A prognostic nomogram was constructed for clinical decisions.

Results: The ROCK was best in both the overlapping and non-overlapping cases performed to assess the prognostic value of platelet-based indices. Patients with categorical platelet-based indices significantly split across two clusters, and those with high values, had a high risk of HCC recurrence (hazard ratio [HR] 1.42, 95% CI 1.09-1.86; p<0.01). Tumor size, number of tumor and blood vessel invasion were also associated with high risk of HCC recurrence (all p<0.01). The nomogram well predicted HCC patient survival at 3 and 5 years.

Conclusions: A cluster of platelet-based indices combined with other clinical covariates could be used for prognosis evaluation in HCC.

MeSH terms

  • Aspartate Aminotransferases / blood
  • Blood Platelets
  • Carcinoma, Hepatocellular / blood*
  • Carcinoma, Hepatocellular / mortality*
  • Carcinoma, Hepatocellular / surgery
  • China
  • Cluster Analysis
  • Humans
  • Liver Neoplasms / blood*
  • Liver Neoplasms / mortality*
  • Liver Neoplasms / surgery
  • Lymphocyte Count
  • Monte Carlo Method*
  • Neoplasm Recurrence, Local / mortality
  • Nomograms
  • Platelet Count
  • Prognosis

Substances

  • Aspartate Aminotransferases